Position
Creative Planning in Stoke Therapeutics, Inc.
Back to the book · All holders of STOK
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $34.2K$31.74 → $32.56
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 41.7K | $1.32M | — | — | — | 0.0% |
| Q1 2026 | 48.1K | $1.57M | $32.56 | $34.2K | $208.3K | 0.0% |